Step into the world of TYK2 research. Discover the concept of the TYK2 pathway and explore how TYK2 mediates the cytokines that are drivers in certain immune-mediated inflammatory diseases, including psoriasis. Join our conversation as we delve into the latest findings, illuminating the path toward better understanding.   Brought to you by: Bristol Myers Squibb   Christine Cornejo, MD is the Director, Dermatology Medical Engagement Lead at Bristol Myers Squibb. She graduated summa cum laude from The Pennsylvania State University with a degree in biomedical engineering and received her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She completed her dermatology residency, serving as chief resident, and fellowship in cutaneous oncology at the University of Pennsylvania. After her training, she became an Instructor at Harvard Medical School and joined the Department of Dermatology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. She served as the Director of Confocal Microscopy and specialized in melanoma and high-risk skin cancer management.